ABBOTT

Analysis of Abbott share price

BUY   SELL
72% of retail investor accounts lose money when trading CFDs with this provider.
 
Chart provided by Tradingview

If you are considering taking a position on Abbott's US share price online, we offer you an article dedicated to this stock in which you will discover a lot of useful information. In particular, you will find out about the precise activities of this American group and how it generates its profits. We will take a few moments to tell you about its main competitors in the market and its recent partnerships. Finally, we will explain how to make a relevant fundamental analysis of this stock with the help of the information to be studied in the news.

Latest news

Abbott: annual targets lowered following Covid decline

16/06/2021 - 14h19

While the health crisis has weighed heavily on the transport sector, it has made biotechs like Abbott richer. Abbott has just lowered its annual targets because of the decline in the pandemic.

Elements that can influence the price of this asset:

Analysis N°1

First of all, we will keep an eye on the technological and medical innovations developed by Abbott, which will of course enable it to stand out from the competition and win customers. Indeed, the group is known for its pioneering solutions that can advance healthcare.

Analysis N°2

The development of Abbott's activities and presence in certain strategic markets is also an element to be monitored, particularly in underdeveloped markets. The Abbott Group can use its experience to develop sustainable solutions around the world.

Analysis N°3

Of course, competition in this sector is also something you should watch out for before trading this stock with developments in new products and treatments or major news such as mergers, acquisitions or disposals.

Analysis N°4

Finally, we will also keep a close eye on the partnerships that this group could set up in the months and years to come.

72% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on Plus500

General presentation of Abbott

Let's now take a moment to learn a little more about Abbott and its specific activities. Indeed, you need to know this group and its different sources of income before you start speculating on its share price and in order to detect all its future stakes.

Abbott Laboratories Group is a US company specialising in the research, development, production and sale of pharmaceutical and medical products.

In order to better understand the activities of this company, it is possible to divide them into different segments according to the share of turnover they generate and in this way :

  • Vascular devices including stent systems, dilatation catheters, arterial closures and others accounted for 38.3% of Abbott Group sales.
  • Diagnostic systems and instruments accounted for 24.2% of group sales.
  • Next come nutrition products, including paediatric nutrition products, nutritional supplements and dietetic products, which generate 23.2% of the company's turnover.
  • Medicines including anaesthetics, antiviral products, antibiotics, inhibitors and anti-inflammatories represent 14.1% of the company's turnover.
  • Finally, 0.2% of turnover is generated by ancillary products.

It is also interesting to know the geographical distribution of this group's activities. The group currently generates 35.7% of its turnover in the United States, 7.4% in China, 5.5% in Germany, 4.5% in Japan, 4.4% in India, 3.3% in Switzerland, 3.1% in the Netherlands and 36.1% in the rest of the world.

Analysis of Abbott share price
72% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on Plus500

The major competitors of Abbott

We now invite you to find out more about the industry in which the Abbott Group operates today and therefore about its main competitors in the market. You need to know which companies offer products similar to Abbott's in order to monitor their news and their influence on prices.

Johnson & Johnson

This US pharmaceutical company specialises in the production of pharmaceutical and medical devices, hygiene products, cosmetics and related services for consumers and healthcare professionals.

Sun Pharmaceutical

This Indian company, which also specialises in the pharmaceutical sector, is also one of Abbott's major competitors.

Pfizer 

There will also be competition from the American group Pfizer, which operates worldwide and is one of the giants in this sector. It should be noted that Pfizer is often known for its numerous mergers with other competing companies.

GlaxoSmithKline 

The GSK group is a British multinational but also one of the 10 giants of the pharmaceutical industry in the world. The company was formed from the merger between Glaxo Wellcome and SmithKline Beecham in 2000.

Sanofi

This French company is another competitor of Abbott. It is a company with activities in both pharmaceuticals with prescription medicines for diabetes, rare diseases, multiple sclerosis and oncology as well as generic medicines and consumer health and care products.


The major partners of Abbott

After discovering the Abbott Group's main competitors, we suggest you learn a little more about its allies with a few examples of the strategic partnerships that the company has recently set up:

Sanofi

In 2019, the Abbott Group entered into a collaborative partnership with Sanofi to integrate blood glucose monitoring and insulin delivery technologies to further simplify the way patients with diabetes manage their disease. As a result, the two companies will pool their innovation capabilities in connected care to develop tools that combine FreeStyle Free technology and insulin dosing data into intelligent pens and insulin dosing applications as well as cloud-based software.

Caprion Pharmaceuticals Inc.

In 2004, Abbott entered into a research collaboration with Caprion Pharmaceuticals Inc. to discover novel therapeutic targets for the development of immunotherapeutic agents for lung cancer and through Caprion's quantitative proteomics platform, CellCarta.

72% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on Plus500

Frequently Asked Questions

Is the Abbott share interesting to trade over the long term?

In order to determine whether it is worth taking long-term positions in Abbott's share price, it is necessary to perform several types of analysis by choosing the period you are interested in. These may include financial data about the company, its strategic development plans, or other indications such as data from technical analysis or the economic health of the industry or global markets.

What are the events that most impact the Abbott action?

If you delve into the historical analysis of Abbott's share price, you will quickly see that some events have had a greater impact on the Abbott share price than others. These include acquisitions and mergers, which have often allowed Abbott to diversify its business and become more profitable with new sources of revenue. These events thus often lead to an upward trend.

Should we focus on technical or fundamental analysis of the Abbott share?

Ideally, you should not use either of these two methods of analysis to trade Abbott's share price. Indeed, the best strategy is to find signals that coincide between these two analyses carried out together, as it is these signals that are most likely to be realized. It is this combination of technical and fundamental analysis that will therefore be the most convincing.

72% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. This is an advert for trading CFDs on Plus500